BlackRock Institutional Trust’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $8.07M | Buy |
339,172
+11,001
| +3% | +$262K | ﹤0.01% | 2521 |
|
|
2016
Q3 | $12M | Buy |
328,171
+3,285
| +1% | +$121K | ﹤0.01% | 2232 |
|
|
2016
Q2 | $7.25M | Buy |
324,886
+2,349
| +0.7% | +$52.4K | ﹤0.01% | 2484 |
|
|
2016
Q1 | $6.71M | Sell |
322,537
-10,442
| -3% | -$217K | ﹤0.01% | 2506 |
|
|
2015
Q4 | $10.1M | Buy |
332,979
+6,504
| +2% | +$197K | ﹤0.01% | 2315 |
|
|
2015
Q3 | $8.06M | Sell |
326,475
-15,977
| -5% | -$395K | ﹤0.01% | 2433 |
|
|
2015
Q2 | $11M | Buy |
342,452
+15,539
| +5% | +$499K | ﹤0.01% | 2346 |
|
|
2015
Q1 | $11.7M | Buy |
326,913
+371
| +0.1% | +$13.2K | ﹤0.01% | 2296 |
|
|
2014
Q4 | $7.41M | Sell |
326,542
-5,480
| -2% | -$124K | ﹤0.01% | 2531 |
|
|
2014
Q3 | $6.44M | Buy |
332,022
+677
| +0.2% | +$13.1K | ﹤0.01% | 2560 |
|
|
2014
Q2 | $12M | Buy |
331,345
+12,908
| +4% | +$469K | ﹤0.01% | 2315 |
|
|
2014
Q1 | $12.4M | Buy |
318,437
+14,644
| +5% | +$568K | ﹤0.01% | 2281 |
|
|
2013
Q4 | $8.66M | Buy |
303,793
+34,145
| +13% | +$973K | ﹤0.01% | 2497 |
|
|
2013
Q3 | $9.65M | Sell |
269,648
-22,563
| -8% | -$808K | ﹤0.01% | 2386 |
|
|
2013
Q2 | $9.76M | Buy |
+292,211
| New | +$9.76M | ﹤0.01% | 2329 |
|